Market Overview

bluebird bio (NASDAQ: BLUE)

127.15 -6.29 (-4.71%)

Analyst Ratings

DateResearch FirmActionCurrentPT
1/23/19Canaccord GenuityMaintainsBuy161.0
12/20/18Raymond JamesInitiates Coverage OnStrong Buy0.0
12/19/18Morgan StanleyMaintainsEqual-Weight125.0
12/06/18PiperJaffrayDowngradesNeutral120.0
11/28/18Leerink SwannInitiates Coverage OnOutperform145.0
11/05/18Morgan StanleyMaintainsEqual-Weight185.0
11/05/18WedbushMaintainsOutperform166.0
11/05/18Janney CapitalUpgradesBuy170.0
10/15/18Morgan StanleyMaintainsEqual-Weight186.0
6/19/18Evercore ISI GroupUpgradesOutperform230.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter